The objective of this study was to evaluate the frequency of CD4 1 T cell subsets in peripheral blood mononuclear cells (PBMC), urine and renal tissue from patients with lupus nephritis (LN). PBMC and urinary cells were collected from 17 patients with active LN, 20 disease controls (DC) with primary glomerulonephritis and 10 healthy controls (HC) and were analysed by flow cytometry with markers for T helper type 1 (Th1), Th2, Th17 and regulatory T cells (T reg ) cells. T cell subsets were assessed by immunohistochemistry from LN biopsy specimens from 12 LN patients. T cell subtypes in PBMC were re-evaluated at 6 months of therapy. CD4 1 T cells were decreased in PBMC in LN compared with DC and HC (P 5 0Á0001). No differences were observed in urinary CD4 1 T cell subsets between LN and DC. The frequency of urinary Th17 cells was higher in patients with non-proliferative than in proliferative LN (P 5 0Á041). CD3 1 and T-box 21 (T 1 bet ) cells were found in glomeruli and interstitium of LN patients, while forkhead box protein 3 (FoxP3), retinoid-related orphan receptor gamma (ROR-g) and GATA binding protein 3 (GATA-3) were present only in glomeruli. Th1 cells in PBMC were correlated negatively with urinary Th1 cells (Rho 5 -0Á531; P 5 0Á028) and with T bet in renal interstitium (Rho 5 -0Á782; P 5 0Á004). At 6 months, LN patients showed an increase in Th17 cells in PBMC. In conclusion, the inverse association between Th1 cells from PBMC and urinary/renal tissue indicate a role for Th1 in LN pathophysiology. Urinary Th17 cells were associated with less severe LN, and Th17 increased in PBMC during therapy. Urinary CD4 1 T cells were not different between LN and DC.
Introduction
Systemic lupus erythematosus (SLE) is a systemic inflammatory disorder of unknown aetiology, classified as an autoimmune disease and characterized by multiple organs and systems involvement with relapse and remission periods [1] . Immunological alterations of SLE include apoptotic cell clearance deficiency, complement activation and autoantibody production. An imbalance in T helper type 1 (Th1)/Th2 response has been regarded as a major factor in SLE pathogenesis, with some studies reporting skewing towards Th2 response in peripheral blood mononuclear cells (PBMC), whereas immunopathology studies have shown a predominant Th1 response in proliferative lupus nephritis (LN) [2, 3] . Recently, other T cell subsets such as Th17 and regulatory T cells (T reg cells) have been implicated in the SLE immunological scenario [4] [5] [6] [7] [8] .
Immunopathology studies of LN have shown Th1, Th2 and Th17 CD4
1 T cells infiltrating active glomerular lesions. However, there seem to be certain peculiarities according to the type and stage of LN. Thus, Th1 cells have not been found in renal interstitial infiltrates of classes III and V LN, whereas Th2 and Th17 cells have been found in both glomerular and interstitial renal compartments in class IV [9] . Interleukin (IL)-17-producing T cells are present in the inflamed kidney and seem to contribute to the inflammatory process [10] , whereas the frequency of CD8 1 forkhead box P3 (FoxP3 1 ) T cells increased in the renal tissue after intravenous methylprednisolone therapy, and is associated with decreased disease activity [11] . In an effort to identify possible associations between cellular or molecular alterations in the urine with clinical parameters of LN a number of urinary biomarkers have been evaluated in recent years, among which urinary T cell counts are promising surrogate markers for active LN. In fact, patients with active LN present increased absolute numbers of CD4 1 and CD8 1 T cells in the urine [12] [13] [14] [15] .
Furthermore, persistence of increased number of urinary CD4 1 T cells and increased expression of FoxP3 mRNA in the urine are predictive of poor treatment response and outcome [13, 16] . These observations highlight the importance of T cells in pathophysiology of LN, and suggest that the evaluation of CD4 1 T cell counts and the balance between different T cell subsets may be helpful in the assessment of disease activity, response to therapy and prognosis in LN. This study aims to evaluate the frequency of urinary CD4 1 T cell subsets in patients with active LN in order to identify associations with clinical, laboratory and immunological parameters.
Materials and methods

Study population
Subjects were divided into three groups: active LN, disease controls (DC) and healthy controls (HC). Seventeen SLE patients with active LN were evaluated prior to therapy, followed-up for 6 months and reassessed for determining the immunosuppressive therapy response according to the American College of Rheumatology (ACR) response criteria for LN, which include three main items: renal function, proteinuria and urinary sediment [17] . According to the follow-up, LN patients were classified as: (1) complete response (i.e. improvement of all three items of the response criteria) and (2) partial response or persistent active LN (i.e. improvement of two or fewer items of the response criteria) [17] . SLE patients were recruited from the Rheumatology Outpatient Clinic at Universidade Federal de São Paulo -Escola Paulista de Medicina (Unifesp-EPM). SLE patients fulfilled the updated ACR SLE classification criteria [18] and presented current active LN. Disease activity was rated by the SLE Disease Activity Index (SLEDAI) [19] . Active LN was considered if the renal biopsy confirmed LN or if patients presented ! 3 items of the renal SLE-DAI, such as urinary casts, haematuria, proteinuria, pyuria, low complement and increased anti-DNA titres [19] . Table 1 
4 (33Á3) Induction therapy for lupus nephritis Cyclophosphamide, n (%) 13 (76Á5) Mycophenolate sodium, n (%) 4 (23Á5) n 5 Number of patients. 
Immunohistochemistry analysis of renal specimens
Serial 2-mm-thick sections of renal biopsy tissue were dewaxed in xylene and rehydrated in graded series of ethanol. After rehydration, antigen retrieval was performed by incubation of sections at 908C for 5 min in citrate buffer at pH 6.0. Endogenous peroxidase was blocked twice for 10 min with hydrogen peroxide 20 vol. Subsequently, sections were incubated overnight at 48C with one of the following: mouse monoclonal immunoglobulin (Ig)G anti-human CD3 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), goat polyclonal IgG anti-human GATA binding protein 3 (GATA-3) (Santa Cruz Biotechnology), rabbit polyclonal IgG anti-human T-box 21 (T bet ) (Santa Cruz Biotechnology), rabbit polyclonal IgG anti-human retinoid-related orphan receptor gamma (ROR-g) (Genway Biotech, San Diego, CA, USA) and rabbit polyclonal IgG anti-human FoxP3 (Genway Biotech). Primary antibodies were detected using horseradish peroxidase-based Novolink kit (Leika Biosystems, Nußloch, Germany) with secondary antibodies for mouse rabbit and gout IgG (Dako Agilent, Santa Clara, CA, USA). Nuclei were counterstained with haematoxylin (Sigma-Aldrich, St Louis, MO, USA).
For measuring glomerular expression of T cell markers, slide images were captured by microscope (Leica DM 1000 microsystems) at 3400 magnification with a CMS DFC310 FX camera. The median number of glomeruli per slide ranged from 10 to 12. The software Las Score V3.8 determined the colour intensity of T cell markers per ml 2 automatically in all glomeruli, and in renal interstitium, results were expressed in percentages. In interstitial inflammatory cell infiltration, each marker was rated in eight random fields (3400 magnification) per tissue specimen and the 
Statistical analysis
Categorical data were presented as percentages and absolute numbers, while continuous variables were presented as mean 6 standard deviation or as median and range, as appropriate. Comparisons between two groups were performed using the v 2 test or Fisher's exact test for categorical data and with Student's t-test or Mann-Whitney U-test for continuous data. One-way analysis of variance (ANOVA) or Kruskal-Wallis tests were used for comparison among ! 3 groups. Correlations were analysed by Spearman's or Pearson's correlation coefficient, as appropriate. ICC was calculated to assess the agreement rate between two blinded observers rating markers in renal biopsies. Longitudinal analysis was carried out with two-way ANOVA for repeated measures, Student's t-test for paired samples, Wilcoxon's signed-rank test and McNemar's test, as appropriate. The accepted significance level was 5% (P < 0Á05). IBM SPSS Statistics for Windows, version 20.0 (Armonk, NY, USA) was used for statistical analysis and graphs were built using GraphPad Prism version 5.0 for Windows (La Jolla, CA, USA).
Results
Decreased frequency of CD4 1 T cells and Th2 cells in peripheral blood from LN patients
We analysed the frequency of peripheral CD4
1 T cells and Th subsets (Th1, Th2, Th17 and T reg ) from LN patients, DC patients and HC (Supporting information, Th subsets in the urine from LN patients
All CD4 1 T cell subsets were detected in the urine from LN and DC patients, whereas CD4 1 T cells could not be detected in urine samples from HC. LN patients and DC presented similar frequencies of CD4 Th subsets in patients with proliferative and non-proliferative LN Among 12 LN patients who underwent renal biopsy, six presented proliferative LN according to Society of Nephrology/Renal Pathology Society (ISN/RPS) classification [20] (i.e. classes III or IV), while six had non-proliferative LN (i.e. classes II or V). Renal specimens with proliferative and non-proliferative lesions did not differ regarding the frequency of peripheral Th1 [0Á10% (0Á0003-2Á50) versus 1Á19% (0Á30-7Á33); P 5 0Á093], Th2 [1Á77% (0Á05-7Á95) versus 1Á66% (0Á38-4Á00); P 5 1Á000], Th17 [15Á02% (1Á70-24Á55) versus 9Á70% (1Á90-11Á92); P 5 0Á588] and T reg cells [1Á79% (0Á49-8Á00) versus 4Á10% (1Á43-5Á00); P 5 0Á309], respectively.
Patients with proliferative LN presented a significantly lower frequency of urinary Th17 cells compared with nonproliferative LN [3Á85% (1Á30-27Á00) versus 14Á37% (4Á42-57Á80), respectively; P 5 0Á041] (Fig. 1) . No significant differences were observed between proliferative and nonproliferative LN regarding the frequency in urine of Th1 
Correlations between CD4
1 T cell subsets, clinical and laboratory parameters in LN
Th2, Th17 and T reg cells) and 24-h proteinuria, leucocyturia, serum CH100 levels, serum C 2 h levels, SLEDAI or serum creatinine (Supporting information, Table S2 ). In contrast, the frequency of urinary T reg cells presented a significant positive correlation with serum CH100 levels (Rho 5 0Á591; P 5 0Á012) and serum C 2 h levels (Rho 5 0Á638; P 5 0Á006) (Supporting information, Fig.  S3a,b) . In addition, the frequency of urinary Th17 cells presented a negative correlation with SLEDAI (Rho 5 20Á487; P 5 0Á048) and with serum creatinine (Rho 5 20Á755; P < 0Á0001) (Supporting information, Fig. S3c,d ). No correlation was found between the frequency of other CD4 1 T cells subsets in urine and 24-h proteinuria, leucocyturia, serum CH100 levels, serum C 2 h levels, SLEDAI or serum creatinine (Supporting information, Table S3 ).
T cell infiltrate in renal tissue of LN
Renal biopsy specimens from 12 patients were evaluated for the expression of the pan T cell, Th1, Th2, Th17 and T reg cell markers. All biopsy specimens were positive for cells bearing CD3 (pan T cell marker) (Supporting information, Fig. S4 ), T bet (Th1 marker), FoxP3 (T reg marker) and ROR-g (Th17 marker) in glomerular infiltrates. In contrast, tubulointerstitial infiltrates showed cells bearing CD3 and T bet in all specimens, but only 30% of specimens had cells expressing FoxP3 and 10% had cells expressing ROR-g. The expression of GATA3 could not be found in tubulointerstitial infiltrates. The percentage of T cell subsets markers in glomeruli occurred in different proportions, as follows: T bet (16Á78 6 3Á67%), GATA3 (15Á42 6 3Á92%), ROR-g (13Á76 6 3Á70%) and FoxP3 (2Á14 6 1Á22%) (P < 0Á0001) (Fig. 2) . The frequency of cells expressing T bet , GATA3 and ROR-g in glomerular infiltrates was significantly higher than those expressing FoxP3. Figure 3 shows representative LN glomerular specimens stained for T cell subset markers and Fig. 4 shows representative LN renal interstitium from renal biopsies specimens stained for T bet , GATA-3, FoxP3 and ROR-g. A negative correlation was found between the frequency of T bet -positive cells in tubulointerstitial specimens and the frequency of Th1 cells in the peripheral blood (Rho 5 20Á782; P 5 0Á004) (Fig. 5a) . Peripheral blood Th1 cells were also correlated negatively with Th1 cells in urine (Fig. 5b) . No correlations were found between glomerular or tubulointerstitial expression of T cell subset markers and 24-h proteinuria, urinary leucocytes, SLEDAI, serum CH100 or C 2 h (Supporting information, Tables S4 and S5 ).
The impact of therapy on Th cell subsets in PBMC
Sixteen LN patients were re-evaluated at 6 months after baseline during the induction therapy. All clinical and laboratory parameters improved at 6 months, except for serum creatinine and lymphocyte count in peripheral blood ( Table 3 ). The frequency of peripheral Th17 cells increased at 6 months of therapy, whereas no difference was found for Th1, Th2 and T reg cells (Fig. 6) .
At 6 months of induction therapy, nine patients achieved complete response (56Á2%) and seven (43Á7%) patients did not: six had a partial response and one had persistent active LN. No significant differences were observed between patients who attained complete response to therapy and those with partial or no response concerning the frequency of Th1, Th2, Th17 and T reg cells in PBMC (Supporting information, Fig. S5 ).
Discussion
In this study, we found a unique pattern of CD4 1 T cell subset distribution in PBMC from patients with active LN that was not shared with DC and HC. Active LN showed a Fig. 2 . Comparison between T cell subsets frequency in glomerular inflammatory infiltration in lupus nephritis. The glomerular expression of T box 21 (T bet ), GATA binding protein 3 (GATA3) and retinoid-related orphan receptor gamma (ROR-g) was significantly higher than forkhead box protein 3 (FoxP3) in lupus nephritis (P < 0Á0001 for each comparison). No significant differences were found among the expression of T bet , GATA3 and ROR-g (P > 0Á05). A low frequency of peripheral CD4 1 T cells from SLE patients may be the result of lymphopenia, a common haematological SLE feature [21] . In this study, the majority of SLE patients presented lymphopenia which is, in turn, associated usually with disease activity and is attributed to circulating complement fixing autoantibodies against lymphocytes [22] . As observed in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis and in patients with sarcoidosis [23, 24] , it is possible that the migration of T lymphocytes from peripheral blood into inflamed tissues contributes to the observed lymphopenia in SLE patients and to the decreased frequency of CD4 1 T cells in peripheral blood from LN patients in this study. This possibility is supported by our finding of a negative correlation between peripheral Th1 cells and urinary Th1 cells, as well as with the frequency of cells expressing T bet in kidney biopsy specimens. These findings are in line with previous studies showing a predominant Th1 response in proliferative forms of LN [2, 3] . Increased expression of IFN-g in T cells and infiltration of macrophages in glomeruli of LN patients with proliferative forms indicate a Th1-driven response [25] . The presence of CD8 1 T cells in the urine from patients with active LN and the absence of these cells in urine during remission stresses the importance of the Th1 response in LN [14] . Furthermore, the absolute number of urinary CD8 1 T cells seems to be a valuable biomarker in discriminating LN from diabetic nephropathy and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis [26] . Regarding the decreased frequency of peripheral blood Th2 cells in LN patients compared with controls, we hypothesize that this may not be associated with migration of Th2 cells to renal tissue, but rather to the fact that the Th2 response may be less relevant for LN pathogenesis [3] . Highlighting the importance Th1 cells in the pathogenesis of LN, Chan et al. showed an increased expression of T bet mRNA and decreased GATA3 mRNA expression in the renal tissue of patients with active LN. In addition, they found elevated T bet /GATA3 and INF-g/IL-4 Table 3 . Clinical and laboratory parameters in patients with lupus nephritis (LN) at baseline and at 6 months of induction therapy
1Á94 (0Á83-18Á17) 0Á28 (0Á06-3Á36) 0Á0015 Urinary leucocytes, cells/ml 79 000 (2000-672 00) 5500 (1000-14 000) 0Á0006 Serum creatinine, mg/dl
Anti-dsDNA 5 anti-double-stranded DNA; CH100 5 total complement activity; n 5 number of patients; SLEDAI 5 systemic lupus erythematosus disease activity index. expression ratios in the urine of these patients [3] . Although patients with membranous LN may present a predominant Th2 response [27] there were only four patients with pure membranous LN, and we found no trend for correlation between peripheral blood or urinary Th2 cells and GATA3 expression in glomeruli (data not shown). The number of LN patients presenting class V was indeed too low in this study to draw definite conclusions about this issue. Some studies have shown that urine samples from patients with LN contain increased absolute numbers of T cells per ml and they can be detected and quantified by flow cytometry analysis [12, 14, 26] . We could not find any specific pattern of urinary CD4
1 T subsets in active LN when comparing with other forms of nephritis. Indeed, to date there is no consensus on which CD4
1 T cell subset is found predominantly in urine from patients with active LN. Nonetheless, Enghard et al. [12] observed an increase in the absolute number of CD4
1
CXCR3
1 T cells in urine from LN patients and this subpopulation represented half of urinary CD4
1 T cells, indicating a predominant Th1 phenotype. Counts of total CD4
1 T cells in urine have been reported to be useful to detect active disease, response to treatment and to be a prognostic marker in LN, indicating a worse clinical outcome and lower treatment response in LN patients with persistent or increasing urinary CD4 1 T cells, despite therapy [12, 13] . In addition, the number of CD8 1 T cells in urine seem to be a good marker for assessment of disease activity and remission in LN [14] . Recently, Kopetschke et al. [26] showed that the urinary CD4/CD8 T cell ratio was significantly lower in SLE with active LN compared with other nephropathies, indicating that this ratio could be useful in discriminating LN and other forms of kidney disease. Conversely, another study showed that the low urinary CD4/CD8 ratio was associated with active SLE without LN, whereas active LN was indeed associated with the high urinary CD4/CD8 ratio. Interestingly, plasmablasts and plasma cells were found in the urine of patients with active LN and a high CD4/CD8 ratio [28] .
The role of Th17 cells in LN is still controversial [9, 29] . Increased glomerular expression of IL-17 has been described in renal tissue from LN patients presenting classes III, IV and V (ISN/RPS) [7, 9] . In the present study, we observed a higher frequency of urinary Th17 cells in non-proliferative compared with proliferative forms of LN. Moreover, we found a negative correlation between the frequency of urinary Th17 cells and SLEDAI, and we observed an increase in peripheral Th17 cells at 6 months of immunosuppressive therapy. These findings are in line with the study by Kwan et al., which showed an inverse correlation between the expression of Th17-related genes in the urinary sediment and systemic and renal disease activity. They also found an increased expression of Th17-related genes in urinary sediment after successful immunosuppressive therapy [29] . Conversely, other studies showed a positive correlation between the frequency of peripheral blood Th17 cells and SLEDAI and an increased expression of IL-17 and IL-23 in glomeruli from LN patients. An increased expression of the co-stimulatory marker CD134 is observed in peripheral Th17 cells as well as in T cells infiltrating glomeruli from patients with active LN, indicating that Th17 cells migrate to the kidney in active LN [7, 10] .
Our data suggest a potential protective role of urinary T reg cells in LN, as the frequency of urinary T reg cells was associated with higher serum complement while the frequency of peripheral T reg cells was correlated inversely with serum creatinine levels. However, other studies have shown an association of urinary T reg cells with the severity of LN and with disease activity of SLE. Wang et al. [16] described increased expression of urinary FoxP3 mRNA in active LN in association with severe outcome and poor response to therapy, and another study showed a positive correlation between urinary T reg cells and SLEDAI in patients with active LN [26] . Whether this association between T reg cells and disease activity/severity in LN is due to a counterregulatory role of these cells remains an open question.
The present study has some limitations that need to be taken into consideration. Although we were able to study a reasonable number of patients with active LN, renal biopsy could not be performed in approximately 30% of patients with LN. In addition, there was considerable histopathological heterogeneity (i.e. Classes II, III, IV and V according to ISN/RPS) among the specimens analysed [20] . Two other issues that need to be interpreted with caution are that analysis of CD4 1 T cells in peripheral blood and in urine are phenotypical and might reflect Th1, Th2 and Th17 subtypes, but the expression of surface markers in CD4 1 T cells may not be a definitive proof of these T cell subtypes. Moreover, the tissue expression of transcription factors as markers of Th cell subtypes in renal biopsies are not completely specific too, as these markers are not expressed solely in CD4 1 T cells. These elements must be taken into consideration in the judicious interpretation of the findings related to CD4 1 T subtypes vis-a-vis the histological classes of LN.
In summary, our results confirm the important role of Th1 cells in the pathogenesis of LN and provide indirect evidence for the migration of these cells from peripheral blood into the renal tissue and subsequently to the urine during active LN. Conversely, urinary T reg and Th17 cells were associated with less severe forms of LN, whereas therapy for LN induced an increase of peripheral Th17 cells. Despite differences in the distribution of some CD4
1 T cell subsets in the peripheral blood from LN patients compared with DC and HC, urinary CD4 1 T cell subsets do not seem to discriminate LN from other glomerulonephritis. However, the determination of T cells in the urine may help in the differentiation between proliferative and nonproliferative forms of LN as well as in monitoring renal disease activity. 
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